Krystal Biotech, Inc. KRYS
Set alert
301.33 USD +5.43 +1.83%
As of Nov 3, 10:12 AM ET
293.26 Day range 305.43
192.52 52-week range 382.54
- YTD
- +22.22%
- 1 year
- +52.30%
- Open
- 293.49
- Prev close
- 295.90
- Mkt cap
- 8.92B
- Vol
- 63.80K
- Avg vol
- 272.85K
- EPS
- 7.36
- P/E
- 40.88
- Div yield
- 0.00%
More statistics
- Low
- 293.26
- High
- 305.43
- Forward P/E
- 33.03
- Beta
- 0.65
- Short ratio
- 9.85
- Inst. own
- 104.39%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 16, 2027
- 50-d avg
- 337.46
- 200-d avg
- 308.53
- 1y target
- 395.44
MAX chart
Events in this range
- Nov 3, 2025Earnings: 2.66; estimate 1.12; surprise 137.5%
- Feb 17, 2026Earnings: 1.7; estimate 1.62; surprise 4.94%
- May 4, 2026Earnings: 1.83; estimate 1.45; surprise 26.21%
- Jun 18, 2026Rating: TD Cowen · Buy → Buy
- Jul 14, 2026Rating: B of A Securities · Buy → Buy
- Aug 3, 2026Earnings: 1.79; estimate 1.7; surprise 5.29%
- Aug 4, 2026Rating: Citigroup · Buy → Buy
- Aug 14, 2026Rating: RBC Capital · — → Outperform
- Sep 21, 2026Rating: B of A Securities · Buy → Buy
- Oct 15, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Nov 2, 2026Earnings: 2.05; estimate 1.79; surprise 14.53%
Signals (210)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 2026 | 1 day ago |
| SMA: Bullish | Oct 26, 2026 | 1 week ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 20, 2026 | 3 months ago |
| RSI: Overbought | Jun 15, 2026 | 4 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| RSI: Overbought | May 11, 2026 | 5 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Mar 2, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bullish | Feb 23, 2026 | 8 months ago |
| SMA: Bearish | Feb 16, 2026 | 8 months ago |
| RSI: Overbought | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
Newest 20 of 210.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 395.44 +31.2% upside
Now 301.33
- Target (low)
- 284.00
- Target (mean)
- 395.44
- Target (high)
- 474.00
Ratings (0m) 12 11 buy · 1 hold · 0 sell
- Strong buy1
- Buy10
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 12
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.92 | 1.49 – 3.04 | 2.66 | -27.9% | 126.54M | +29.4% | 10 |
| Next quarter | 2.01 | 1.69 – 3.12 | 1.70 | +18.4% | 134.28M | +25.4% | 10 |
| Current year | 7.59 | 6.77 – 10.26 | 6.84 | +10.9% | 496.69M | +27.6% | 11 |
| Next year | 8.95 | 6.47 – 11.97 | 7.59 | +18.0% | 634.23M | +27.7% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 15, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 21, 2026 | B of A Securities | Maintained | Buy | Buy |
| Aug 14, 2026 | RBC Capital | Initiated | — | Outperform |
| Aug 4, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 14, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jun 18, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jun 16, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jun 1, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 22, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 18, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 5, 2026 | Citigroup | Maintained | Buy | Buy |
| May 5, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 4, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 27, 2026 | Wolfe Research | Initiated | — | Peer Perform |
| Feb 25, 2026 | Guggenheim | Maintained | Buy | Buy |
| Feb 18, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 18, 2026 | Chardan Capital | Maintained | Buy | Buy |
| Feb 17, 2026 | Jefferies | Maintained | Buy | Buy |
| Feb 2, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Jan 22, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jan 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 9, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jan 9, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 9, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 6, 2026 | Citigroup | Upgrade | Neutral | Buy |
| Nov 4, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Nov 4, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Oct 17, 2025 | B of A Securities | Maintained | Buy | Buy |
| Sep 15, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 22, 2025 | Chardan Capital | Maintained | Buy | Buy |